A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue.

Ebere Sonoiki, Caroline L. Ng, Marcus C. S. Lee, Denghui Guo, Yong-Kang Zhang, Yasheen Zhou, M. R. K. Alley, Vida Ahyong, Laura M. Sanz, Maria Jose Lafuente-Monasterio, Chen Dong, Patrick G Schupp, Jiri Gut, Jenny Legac, Roland A. Cooper, Francisco-Javier Gamo, Joseph DeRisi, Yvonne R. Freund, David A. Fidock, Philip J. Rosenthal

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalDefault journal
Volume8
DOIs
StatePublished - Mar 6 2017

Keywords

  • Amino Acid Sequence
  • Animals
  • Antimalarials
  • Boron Compounds
  • CRISPR-Cas Systems
  • Catalytic Domain
  • Cleavage And Polyadenylation Specificity Factor
  • Drug Resistance
  • Erythrocytes
  • Gene Editing
  • Humans
  • Malaria
  • Falciparum
  • Mice
  • Molecular Docking Simulation
  • Mutation
  • Plasmodium berghei
  • Plasmodium falciparum
  • Protein Binding
  • Protein Interaction Domains and Motifs
  • Protein Structure
  • Secondary
  • Protozoan Proteins
  • RNA
  • Messenger
  • Sequence Alignment
  • Sequence Homology
  • Amino Acid
  • Trophozoites

Disciplines

  • Immunology and Infectious Disease

Cite this